About Us2025-01-29T21:49:32-05:00

About Us

Clinilabs is a global, full-service CRO focused exclusively on CNS drug, device, and technology development. With deep expertise in CNS, Clinilabs is committed to developing therapies that address a range of psychiatric, neurological, and substance use disorders, as well as rare and ultra-rare CNS disorders. Clinilabs partners with pharmaceutical, biotechnology, and medical device companies to provide a comprehensive spectrum of high-quality, timely, and cost-effective clinical drug development services from first-in-human to Phase 3 trials, all aimed at accelerating the development of new CNS therapies. Since 2000, Clinilabs has conducted more than 750 CNS clinical trials and has been instrumental in the approval of 22 new therapies across 13 CNS indications, significantly impacting the lives of patients worldwide.

YouTube video player 1

Our Mission

Clinilabs’ mission is to provide high-quality, prompt, and cost-effective drug and device development services to its clients in the interest of delivering new therapeutics to those in need.

Our vision is to become the leading CRO dedicated to providing CNS drug development services.

Our Vision

Clinilabs’ vision is to become the leading contract research organization (CRO) dedicated to providing CNS clinical development services.

We aspire to a

Our Culture

Clinilabs aspires to a “culture of quality” in which all our decisions and actions represent our dedication to quality in clinical development and health care.

Volunteers

We empower study participants through informed decisions regarding study participation.

Investigators

Clinilabs offers a full range of Phase I, II and III clinical development services.

Go to Top